Project duration:
Read more: Project 6 – Targeting Metabolic-Epigenetic Vulnerabilities to Overcome Treatment Resistance
Read more: Project 4 – Targeting TADA2B-SAGA activity to overcome immune cell evasion in ACC
Read more: Project 5 – Targeting WNT5A-Mediated Crosstalk with the Tumor Microenvironment in ACC
